Healthcare provider profile · identity verified

Marjorie Yvonne Devries, M.D

Internal Medicine · PITTSFIELD, MA · NPI 1962438135

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	379	99
Atorvastatin Calcium	Atorvastatin Calcium	334	99
Hydrochlorothiazide	Hydrochlorothiazide	319	83
Omeprazole	Omeprazole	282	79
Lisinopril	Lisinopril	278	81
Pravastatin Sodium	Pravastatin Sodium	278	75
Losartan Potassium	Losartan Potassium	215	66
Amlodipine Besylate	Amlodipine Besylate	211	61
Gabapentin	Gabapentin	158	42
Furosemide	Furosemide	157	46
Lorazepam	Lorazepam	154	69
Duloxetine Hcl	Duloxetine Hcl	149	36
Alendronate Sodium	Alendronate Sodium	148	45
Metoprolol Succinate	Metoprolol Succinate	131	38
Rosuvastatin Calcium	Rosuvastatin Calcium	128	35
Citalopram Hbr	Citalopram Hydrobromide	126	37
Pantoprazole Sodium	Pantoprazole Sodium	122	27
Metformin Hcl Er	Metformin Hcl	121	27
Eliquis	Apixaban	118	27
Albuterol Sulfate Hfa	Albuterol Sulfate	112	31
Fluoxetine Hcl	Fluoxetine Hcl	106	24
Sertraline Hcl	Sertraline Hcl	101	33
Valsartan	Valsartan	92	15
Simvastatin	Simvastatin	80	19
Buspirone Hcl	Buspirone Hcl	79	19
Montelukast Sodium	Montelukast Sodium	79	16
Allopurinol	Allopurinol	76	20
Mirtazapine	Mirtazapine	76	21
Fluticasone Propionate	Fluticasone Propionate	73	28
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	73	17
Atenolol	Atenolol	69	21
Metformin Hcl	Metformin Hcl	69	27
Escitalopram Oxalate	Escitalopram Oxalate	68	15
Trazodone Hcl	Trazodone Hcl	67	15
Prednisone	Prednisone	64	34
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	63	17
Bupropion Xl	Bupropion Hcl	57	14
Warfarin Sodium	Warfarin Sodium	56	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	53	23
Valacyclovir	Valacyclovir Hcl	53	17
Metoprolol Tartrate	Metoprolol Tartrate	52	17
Glimepiride	Glimepiride	51	12
Torsemide	Torsemide	51	suppressed
Irbesartan	Irbesartan	50	13
Synthroid	Levothyroxine Sodium	48	14
Ozempic	Semaglutide	46	suppressed
Alprazolam	Alprazolam	45	18
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	45	15
Ezetimibe	Ezetimibe	44	suppressed
Paroxetine Hcl	Paroxetine Hcl	43	12
Zolpidem Tartrate	Zolpidem Tartrate	43	21
Lamotrigine	Lamotrigine	42	suppressed
Trulicity	Dulaglutide	42	suppressed
Chlorthalidone	Chlorthalidone	41	17
Tizanidine Hcl	Tizanidine Hcl	40	11
Ondansetron Odt	Ondansetron	39	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	39	20
Ibuprofen	Ibuprofen	38	19
Ventolin Hfa	Albuterol Sulfate	38	11
Jardiance	Empagliflozin	37	suppressed
Felodipine Er	Felodipine	36	12
Potassium Chloride	Potassium Chloride	32	suppressed
Clonazepam	Clonazepam	31	11
Estradiol	Estradiol	31	suppressed
Oxycodone Hcl	Oxycodone Hcl	31	11
Divalproex Sodium	Divalproex Sodium	30	suppressed
Jantoven	Warfarin Sodium	30	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	30	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	29	suppressed
Pregabalin	Pregabalin	29	suppressed
Lansoprazole	Lansoprazole	28	suppressed
Tramadol Hcl	Tramadol Hcl	28	15
Amitriptyline Hcl	Amitriptyline Hcl	27	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	27	suppressed
Famotidine	Famotidine	27	11
Hydroxyzine Hcl	Hydroxyzine Hcl	27	suppressed
Nystatin	Nystatin	27	16
Rybelsus	Semaglutide	25	suppressed
Donepezil Hcl	Donepezil Hcl	24	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Carvedilol	Carvedilol	22	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	22	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	22	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	21	18
Ropinirole Hcl	Ropinirole Hcl	20	suppressed
Spironolactone	Spironolactone	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	13
Baclofen	Baclofen	19	suppressed
Clopidogrel	Clopidogrel Bisulfate	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	19	17
Glipizide Er	Glipizide	19	suppressed
Spiriva Handihaler	Tiotropium Bromide	19	suppressed
Carisoprodol	Carisoprodol	18	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	17	suppressed
Bupropion Hcl Sr	Bupropion Hcl	17	suppressed
Amoxicillin	Amoxicillin	16	14
Clotrimazole	Clotrimazole	16	11
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Glipizide	Glipizide	16	suppressed
Mupirocin	Mupirocin	16	suppressed
Clobetasol Propionate	Clobetasol Propionate	15	suppressed
Lidocaine	Lidocaine	15	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	15	15
Propranolol Hcl	Propranolol Hcl	15	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	14	suppressed
Diazepam	Diazepam	14	11
Humalog Kwikpen U-100	Insulin Lispro	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Risedronate Sodium	Risedronate Sodium	14	suppressed
Aripiprazole	Aripiprazole	13	suppressed
Cephalexin	Cephalexin	13	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Mounjaro	Tirzepatide	13	suppressed
Naproxen	Naproxen	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	13	suppressed
Testosterone Cypionate	Testosterone Cypionate	13	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Lamotrigine Er	Lamotrigine	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	11	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error